Status:

COMPLETED

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

Lead Sponsor:

JADO Technologies GmbH

Conditions:

Cutaneous Mastocytosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The current study will investigate the effects of TF002 on cutaneous mastocytosis or cutaneous involvement of systemic mastocytosis as compared to clobetasol proprionate (positive control) and a gener...

Detailed Description

This is a randomised, double-blind, placebo- and active-controlled study with intra-individual comparison of test areas. The primary study target is to evaluate the safety and efficacy of TF002 for t...

Eligibility Criteria

Inclusion

  • Chronic stable symptomatic maculopapulous cutaneous mastocytosis or systemic mastocytosis with involvement of the skin and with positive Darier's Sign
  • 3 comparable skin lesional areas
  • Otherwise healthy according to physical examination
  • Informed consent signed and dated

Exclusion

  • Aggressive systemic mastocytosis
  • Other dermatological diseases at treated skin site
  • Known hypersensitivity to study drugs or their components
  • Mental disorders
  • Drug or alcohol dependency
  • Any other chronic or acute illness requiring systemic treatment which might have any influence on the outcome of the study in the 4 weeks before start of treatment and during the study (investigator's decision).
  • Immunodeficiency including HIV
  • Pregnancy or lactation
  • Participation in another clinical trial within the last 30 days
  • Malignant skin lesions
  • Radiation therapy of target areas excluding UV therapy longer then 4 weeks before start of study treatment
  • Dermal comorbidities within the target areas
  • Any concomitant medication which might influence the study objectives or are known to provoke or aggravate mastocytosis

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2007

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00457288

Start Date

April 1 2007

End Date

September 1 2007

Last Update

November 12 2007

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Klinik und Poliklinik für Dermatologie und Venerologie der Universität

Cologne, Köln, Germany, D-50924

2

Universitäts-Hautklinik

Mainz, Germany, D-55131

3

Klinik und Poliklinik für Dermatologie und Allergologie der LMU

München, Germany, D-80337

4

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU

München, Germany, D-80802